Similarly, inhibiting B-lymphocyte activity or knockout B-lymphocyte activity in PAH rats decreased trypsin, vascular endothelial growth factor, and leukotriene 4 (LTE 4) levels in PAH patients (93, 94). The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.